Previous studies have mentioned that DCs are among the primary regulators for the beginning of allergic reactions in AD patients, being aggressively activated by epithelial-cell-derived thymic stromal lymphopoietin (TSLP), a cytokine that can dramatically upregulate the expression of CD83. Here, TSLP is linked to Alzheimer disease.